Sue Hammoud, PhD, Awarded "Judges Choice Award in Therapeutics" at the 6th Annual Equalize Startups Culmination Pitch Event

Diverse attendees from across the nation gathered to celebrate groundbreaking ideas and entrepreneurial excellence at the 6th Annual Equalize Startups Culmination Pitch Event.

The event kicked off with a welcome and keynote address by Nancy Briefs, serial life science CEO, followed by thirty-five talented Equalizers pitching their innovations in four exciting categories: Medical Technologies, Tools, Therapeutics, and Physical Sciences. 

Sue Hammoud, PhD, from the Department of Human Genetics, was selected as the recipient of the "Judges' Choice Award in Therapeutics". Congratulations, Dr. Hammoud, on driving change and increasing the successful participation of female academics in innovation and entrepreneurship. 

Out of the thirty-five talented women who pitched their innovations, the eight winners are listed below:

🔬 MEDTECH 
Judge's Choice Award: Dr. Ahna Skop from University of Wisconsin-Madison 
People’s Choice Award: Fateme Fayyazbakhsh from Missouri University of Science and Technology 

⚛️ PHSYICAL SCIENCES
Judge's Choice Award: Warda Ashraf from The University of Texas at Arlington
People’s Choice Award: Varsha Shukla from Dartmouth College 

💻 TOOLS 
Judge's Choice Award: Jenna Whalen from UMass Chan Medical School 
People’s Choice Award: Beatriz Martinez-Martin from University of Massachusetts Amherst 

🧬THERAPEUTICS 
Judge's Choice Award: Saher Sue Hammoud from University of Michigan 
People’s Choice Award: Carolina Haass-Koffler, PharmD, PhD from Brown University

Original information posted in the 6th Annual Equalize Startups LinkedIn Post.